These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

656 related articles for article (PubMed ID: 3125490)

  • 1. Analysis of peptide histidine-isoleucine/vasoactive intestinal polypeptide-immunoreactive neurons in the central nervous system with special reference to their relation to corticotropin releasing factor- and enkephalin-like immunoreactivities in the paraventricular hypothalamic nucleus.
    Hökfelt T; Fahrenkrug J; Ju G; Ceccatelli S; Tsuruo Y; Meister B; Mutt V; Rundgren M; Brodin E; Terenius L
    Neuroscience; 1987 Dec; 23(3):827-57. PubMed ID: 3125490
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Distribution and coexistence of corticotropin-releasing factor-, neurotensin-, enkephalin-, cholecystokinin-, galanin- and vasoactive intestinal polypeptide/peptide histidine isoleucine-like peptides in the parvocellular part of the paraventricular nucleus.
    Ceccatelli S; Eriksson M; Hökfelt T
    Neuroendocrinology; 1989 Mar; 49(3):309-23. PubMed ID: 2469987
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Colocalization of peptide histidine isoleucine amine and corticotropin-releasing factor immunoreactivity in neurons of the rat hypothalamus: a surprising artefact.
    Berkenbosch F; Linton EA; Tilders FJ
    Neuroendocrinology; 1986; 44(3):338-46. PubMed ID: 3543717
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Vasoactive intestinal polypeptide/peptide histidine isoleucine immunoreactive neuron systems in the basal hypothalamus of the rat with special reference to the portal vasculature: an immunohistochemical and in situ hybridization study.
    Ceccatelli S; Fahrenkrug J; Villar MJ; Hökfelt T
    Neuroscience; 1991; 43(2-3):483-502. PubMed ID: 1922780
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Concentrations and distribution of vasoactive intestinal peptide (VIP), peptide histidine isoleucine (PHI) and peptide histidine valine (PHV) in the cerebral cortex and the suprachiasmatic nucleus of the mouse.
    Mikkelsen JD; Fahrenkrug J
    Brain Res; 1994 Sep; 656(1):95-107. PubMed ID: 7804850
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Localization of chemical messengers in magnocellular neurons of the hypothalamic supraoptic and paraventricular nuclei: an immunohistochemical study using experimental manipulations.
    Meister B; Villar MJ; Ceccatelli S; Hökfelt T
    Neuroscience; 1990; 37(3):603-33. PubMed ID: 1701038
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Molecular forms of peptide histidine isoleucine-like immunoreactivity in the gastrointestinal tract. Nonequimolar levels of peptide histidine isoleucine and vasoactive intestinal peptide in the stomach explained by the presence of a big peptide histidine isoleucine-like molecule.
    Yiangou Y; Christofides ND; Blank MA; Yanaihara N; Tatemoto K; Bishop AE; Polak JM; Bloom SR
    Gastroenterology; 1985 Sep; 89(3):516-24. PubMed ID: 3839480
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Distribution of vasoactive intestinal peptide- and peptide histidine isoleucine amide-like immunoreactive neurons and fibers in the thoracic spinal cord of the rat.
    Sasek CA; Baldwin C; Zigmond RE
    Brain Res; 1991 Dec; 567(1):159-64. PubMed ID: 1815824
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Further analysis of presence of peptides in dopamine neurons. Cholecystokinin, peptide histidine-isoleucine/vasoactive intestinal polypeptide and substance P in rat supramammillary region and mesencephalon.
    Seroogy K; Tsuruo Y; Hökfelt T; Walsh J; Fahrenkrug J; Emson PC; Goldstein M
    Exp Brain Res; 1988; 72(3):523-34. PubMed ID: 2466680
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Evidence that some preganglionic sympathetic neurons in the rat contain vasoactive intestinal peptide- or peptide histidine isoleucine amide-like immunoreactivities.
    Baldwin C; Sasek CA; Zigmond RE
    Neuroscience; 1991; 40(1):175-84. PubMed ID: 1711174
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Coexistence of corticotropin-releasing factor and enkephalin in the paraventricular nucleus of the rat.
    Pretel S; Piekut D
    J Comp Neurol; 1990 Apr; 294(2):192-201. PubMed ID: 2332527
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Large calibre primary afferent neurons projecting to the gracile nucleus express neuropeptide Y after sciatic nerve lesions: an immunohistochemical and in situ hybridization study in rats.
    Zhang X; Meister B; Elde R; Verge VM; Hökfelt T
    Eur J Neurosci; 1993 Nov; 5(11):1510-9. PubMed ID: 7506974
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Distribution of corticotropin releasing factor-like immunoreactivity in the rat brain by immunohistochemistry and radioimmunoassay: comparison and characterization of ovine and rat/human CRF antisera.
    Skofitsch G; Jacobowitz DM
    Peptides; 1985; 6(2):319-36. PubMed ID: 3875839
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The presence of nerve fibers immunoreactive for vasoactive intestinal peptide (VIP), peptide histidine isoleucine (PHI), and preproVIP(111-122) in the mouse pineal gland.
    Mikkelsen JD; Møller M; Larsen PJ; Fahrenkrug J
    J Pineal Res; 1994 Jan; 16(1):50-6. PubMed ID: 8158524
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Coexistence of glucocorticoid receptor-like immunoreactivity with neuropeptides in the hypothalamic paraventricular nucleus.
    Ceccatelli S; Cintra A; Hökfelt T; Fuxe K; Wikström AC; Gustafsson JA
    Exp Brain Res; 1989; 78(1):33-42. PubMed ID: 2591516
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Distribution and origin of corticotropin-releasing factor-immunoreactive axons in the female rat lumbosacral spinal cord.
    Puder BA; Papka RE
    J Neurosci Res; 2001 Dec; 66(6):1217-25. PubMed ID: 11746455
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Vasoactive intestinal peptide- and peptide histidine isoleucine amide-like immunoreactivity colocalize with vasopressin-like immunoreactivity in the canine hypothalamo-neurohypophysial neuronal system.
    Okamura H; Murakami S; Fukui K; Uda K; Kawamoto K; Kawashima S; Yanaihara N; Ibata Y
    Neurosci Lett; 1986 Sep; 69(3):227-32. PubMed ID: 3531928
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Corticotropin releasing factor-like immunoreactivity in afferent projections to the sacral spinal cord of the cat.
    Kawatani M; Suzuki T; de Groat WC
    J Auton Nerv Syst; 1996 Dec; 61(3):218-26. PubMed ID: 8988478
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The PHI (PHI-27)/corticotropin-releasing factor/enkephalin immunoreactive hypothalamic neuron: possible morphological basis for integrated control of prolactin, corticotropin, and growth hormone secretion.
    Hökfelt T; Fahrenkrug J; Tatemoto K; Mutt V; Werner S; Hulting AL; Terenius L; Chang KJ
    Proc Natl Acad Sci U S A; 1983 Feb; 80(3):895-8. PubMed ID: 6298781
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Survey of distribution of substance P, vasoactive intestinal polypeptide, cholecystokinin, neurotensin, Met-enkephalin, bombesin and PHI in the spinal cord of cat, dog, sloth and monkey.
    Yaksh TL; Michener SR; Bailey JE; Harty GJ; Lucas DL; Nelson DK; Roddy DR; Go VL
    Peptides; 1988; 9(2):357-72. PubMed ID: 2453858
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 33.